BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Teva
Cerilliant
Citi
Queensland Health
Argus Health
Novartis
Colorcon
McKinsey
Healthtrust

Generated: January 22, 2018

DrugPatentWatch Database Preview

VERSAPEN Drug Profile

« Back to Dashboard

When do Versapen patents expire, and when can generic versions of Versapen launch?

Versapen is a drug marketed by Bristol and is included in three NDAs.

The generic ingredient in VERSAPEN is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.

US Patents and Regulatory Information for VERSAPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 061398-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 061398-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 050060-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol VERSAPEN hetacillin FOR SUSPENSION;ORAL 050060-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Merck
Dow
Johnson and Johnson
Fuji
Chubb
Deloitte
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot